Evidence map›Paper›PMID 39280936›Full record

ArticleACS sustainable chemistry & engineering2024

Optimized Spatial Configuration of Heterogeneous Biocatalysts Maximizes Cell-Free Biosynthesis of ω-Hydroxy and ω-Amino Acids.

Javier Santiago-Arcos, Susana Velasco-Lozano, Eleftheria Diamanti, Ana I Benítez-Mateos, Daniel Grajales-Hernández, Francesca Paradisi, Fernando López-Gallego

Abstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Biocatalytic access to betazole using a one-pot multienzymatic system in continuous flow.Green chemistry : an international journal and green chemistry resource : GC · 2021
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Javier Santiago-ArcosHeterogeneous Biocatalysis Group, CIC biomaGUNE, Edificio Empresarial "C", Paseo de Miramón 182, 20009 Donostia, Spain.
Susana Velasco-LozanoHeterogeneous Biocatalysis Group, CIC biomaGUNE, Edificio Empresarial "C", Paseo de Miramón 182, 20009 Donostia, Spain.ORCID https://orcid.org/0000-0001-9478-6750
Eleftheria DiamantiHeterogeneous Biocatalysis Group, CIC biomaGUNE, Edificio Empresarial "C", Paseo de Miramón 182, 20009 Donostia, Spain.
Ana I Benítez-MateosDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Daniel Grajales-HernándezHeterogeneous Biocatalysis Group, CIC biomaGUNE, Edificio Empresarial "C", Paseo de Miramón 182, 20009 Donostia, Spain.
Francesca ParadisiDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.ORCID https://orcid.org/0000-0003-1704-0642
Fernando López-GallegoHeterogeneous Biocatalysis Group, CIC biomaGUNE, Edificio Empresarial "C", Paseo de Miramón 182, 20009 Donostia, Spain.ORCID https://orcid.org/0000-0003-0031-1880

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-free biocatalysis is gaining momentum in producing value-added chemicals, particularly in stepwise reaction cascades. However, the stability of enzyme cascades in industrial settings is often compromised when free enzymes are involved. In this study, we have developed a stable multifunctional heterogeneous biocatalyst coimmobilizing five enzymes on microparticles to transform 1,ω-diols into 1,ω-hydroxy acids. We improved the operational efficiency and stability of the heterogeneous biocatalyst by fine-tuning the enzyme loading and spatial organization. Stability issues are overcome through postimmobilization polymer coating. The general applicability of this heterogeneous biocatalyst is demonstrated by its scale-up in both batch and packed bed reactors, allowing a product yield of >80%. The continuous process is fed with H

Identifiers

PMID39280936
PMCPMC11394354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.